Do trans fatty acids increase the risk of coronary artery disease? A critique of the epidemiologic evidence

American Journal of Clinical Nutrition

Volumn 66, Issue 4 SUPPL., 1997, Pages

  Shapiro, Samuel ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Bias; Confounding; Coronary disease; Critique; Misclassification; trans Fatty acids

Indexed keywords

FATTY ACID; MARGARINE;

CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; FAT INTAKE; HUMAN; LIPID COMPOSITION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0030870207     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.4.1011S     Document Type: Conference Paper

References (33)

1. Willett WC, Ascherio A. Trans fatty acids: are the effects only marginal. Am J Public Health 1994;84:722-4.
2. Willett WC, Stampfer MJ, Manson JE, et al. Trans-fatty acid intake in relation to risk of coronary heart disease among women. Lancet 1993;341:581-5.
3. Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, Willett WC. Trans fatty acid intake and risk of myocardial infarction. Circulation 1994;89:94-101.
4. Diet roulette. New York Times 1994 May 20 (editorial).
5. Breathed B. Outland. Boston Sunday Globe 1994 July 3 (comic strip).
6. Lewis B. The hyperlipidaemias. Clinical and laboratory practice. Oxford: Black Scientific Publications, 1976:343-72.
7. Emken EA. Nutrition and biochemistry of trans and positional fatty acid isomers in hydrogenated oils. Ann Rev Nutr 1984;4:339-76.
8. Dupont J, White PJ, Feldman EB. Saturated and hydrogenated fats in food in relation to health. J Am Coll Nutr 1991;10:577-92.
9. Mann GV. Metabolic consequences of dietary trans fatty acids. Lancet 1994;343:1268-71.
10. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol level in healthy subjects. N Engl J Med 1990;323:439-45.
11. Zock PL, Katan MB. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 1992;33:399-410.
12. Wood R, Kubena K, O'Brien B, Tseng S, Martin G. Effect of butter, mono- and polyunsaturated fatty acid-enriched butter, trans fatty acid margarine, and zero trans fatty acid margarine on serum lipids and lipoproteins in healthy men. J Lipid Res 1993;34:1-11.
13. Nestel P, Noakes M, Belling B, et al. Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992;33:1029-36.
14. Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Ordovas JM, Schaefer EJ. Hydrogenation impairs the hypolipidemic effect on corn oil in humans. Hydrogenation, trans fatty acids, and plasma lipids. Arterioscler Thromb 1993;13:154-61.
15. Bingham SA. Limitations of the various methods for collecting dietary intake data. Ann Nutr Metab 1991;35:117-27.
16. Bates CJ, Thurnham DI, Bingham SA, Margetts BM, Nelson M. Biochemical markers of nutrient intake. In: Margetts BM, Nelson M, eds. Design concepts in nutritional epidemiology. Oxford, United Kingdom: Oxford University Press, 1991:192-265.
17. Mitchell AA, Schwingl PJ, Rosenberg L, Louik C, Shapiro S. Birth defects in relation to Bendectin use in pregnancy. II. Pyloric stenosis. Am J Obstet Gynecol 1983;147:737-42.
18. Slone D, Shapiro S, Miettinen OS, Finkle WD, Stolley PD. Drug evaluation after marketing. A policy perspective. Ann Intern Med 1979;90:257-61.
19. Miettinen O. Efficacy of therapeutic practice: will epidemiology provide the answers? In: Melmon KL, ed. Drug therapeutics: concepts for physicians. New York: Elsevier North Holland, 1980:201-8.
20. Thomas LH. Mortality from arteriosclerotic heart disease and consumption of hydrogenated oils and fats. Br J Prev Soc Med 1975;29:82-90.
21. Troisi R, Willett WC, Weiss ST. Trans-fatty acid intake in relation to serum lipid concentrations in adult men. Am J Clin Nutr 1992;56:1019-24.
22. Bell B, Rose CL, Damon A. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev 1972;3:5-17.
23. Siguel EN, Lerman RH. Trans-fatty acid patterns in patients with angiographically documented coronary artery disease. Am J Cardiol 1993;71:916-20.
24. Siguel EN, Chee KM, Gong J, Schaffer ET. Criteria for essential fatty acid deficiency in plasma as assessed by capillary column gas-liquid chromatography. Clin Chem 1987;33:1869-73.
25. Tzonou A, Kalandidi A, Trichopoulou A, et al. Diet and coronary heart disease: a case-control study in Athens, Greece. Epidemiology 1993;4:511-6.
26. London SJ, Sacks FM, Caesar J, Stampfer MJ, Siguel E, Willett WC. Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr 1991;54:340-5.
27. Hunter DJ, Rimm EB, Sacks FM, et al. Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol 1992;135:418-27.
28. Aro A, Kardinaal AFM, Salminen I, et al. Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study. Lancet 1995;345:273-8.
29. Roberts TL, Wood DA, Riemersma RA, Gallagher PJ, Lampe FC. Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet 1995;345:278-82.
30. Rossouw JE, Finnegan LP, Harlan WR, Pinn VW, Clifford C, McGowan JA. The evolution of the Women's Health Initiative. J Am Med Womens Assoc 1995;50:50-5.
31. Trans fatty acids and coronary heart disease risk. Report of the Expert Panel on Trans Fatty Acids and Coronary Heart Disease. Am J Clin Nutr 1995;62:655S-708S;discussion 518-26.
32. Watts GF, Jackson P, Burke V, Lewis B. Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr 1996;64:202-9.
33. Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995;24:308-15.